This will take effect November 18, 2013
Overview and Clinical Utility:
Effective November 18, 2013, PathGroup will implement in-house Hemoglobin Evaluation testing utilizing agarose gel electrophoresis. Protein electrophoresis is a well-established technique routinely used for the screening of protein abnormalities. The resulting qualitative (or structural) abnormalities are called hemoglobinopathies. Additionally, decreased synthesis of one of the hemoglobin chains leads to quantitative (or regulation) abnormalities, called thalassemias.
Click Here to read more.